About us
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Our Strategic Road Map defines strategies, standards, and policy frameworks to support responsible global use of genomic and related health data.
Discover how a meeting of 50 leaders in genomics and medicine led to an alliance uniting more than 5,000 individuals and organisations to benefit human health.
GA4GH Inc. is a not-for-profit organisation that supports the global GA4GH community.
The GA4GH Council, consisting of the Executive Committee, Strategic Leadership Committee, and Product Steering Committee, guides our collaborative, globe-spanning alliance.
The Funders Forum brings together organisations that offer both financial support and strategic guidance.
Learn how GA4GH is working to expand its global reach and cultivate connection and meaningful engagement with members of the international genomics and health community.
Distributed across a number of Host Institutions, our staff team supports the mission and operations of GA4GH.
Curious who we are? Meet the people and organisations across six continents who make up GA4GH.
More than 500 organisations connected to genomics — in healthcare, research, patient advocacy, industry, and beyond — have signed onto the mission and vision of GA4GH as Organisational Members.
These core Organisational Members are genomic data initiatives that have committed resources to guide GA4GH work and pilot our products.
This subset of Organisational Members whose networks or infrastructure align with GA4GH priorities has made a long-term commitment to engaging with our community.
Local and national organisations assign experts to spend at least 30% of their time building GA4GH products.
Anyone working in genomics and related fields is invited to participate in our inclusive community by creating and using new products.
Wondering what GA4GH does? Learn how we find and overcome challenges to expanding responsible genomic data use for the benefit of human health.
Study Groups define needs. Participants survey the landscape of the genomics and health community and determine whether GA4GH can help.
Work Streams create products. Community members join together to develop technical standards, policy frameworks, and policy tools that overcome hurdles to international genomic data use.
GIF solves problems. Organisations in the forum pilot GA4GH products in real-world situations. Along the way, they troubleshoot products, suggest updates, and flag additional needs.
GIF Projects are community-led initiatives that put GA4GH products into practice in real-world scenarios.
The GIF AMA programme produces events and resources to address implementation questions and challenges.
NIF finds challenges and opportunities in genomics at a global scale. National programmes meet to share best practices, avoid incompatabilities, and help translate genomics into benefits for human health.
Communities of Interest find challenges and opportunities in areas such as rare disease, cancer, and infectious disease. Participants pinpoint real-world problems that would benefit from broad data use.
The Technical Alignment Subcommittee (TASC) supports harmonisation, interoperability, and technical alignment across GA4GH products.
Find out what’s happening with up to the minute meeting schedules for the GA4GH community.
See all our products — always free and open-source. Do you work on cloud genomics, data discovery, user access, data security or regulatory policy and ethics? Need to represent genomic, phenotypic, or clinical data? We’ve got a solution for you.
All GA4GH standards, frameworks, and tools follow the Product Development and Approval Process before being officially adopted.
Learn how other organisations have implemented GA4GH products to solve real-world problems.
Help us transform the future of genomic data use! See how GA4GH can benefit you — whether you’re using our products, writing our standards, subscribing to a newsletter, or more.
Join our community! Explore opportunities to participate in or lead GA4GH activities.
Help create new global standards and frameworks for responsible genomic data use.
Align your organisation with the GA4GH mission and vision.
Want to advance both your career and responsible genomic data sharing at the same time? See our open leadership opportunities.
Join our international team and help us advance genomic data use for the benefit of human health.
Discover current opportunities to engage with GA4GH. Share feedback on our products, apply for volunteer leadership roles, and contribute your expertise to shape the future of genomic data sharing.
Solve real problems by aligning your organisation with the world’s genomics standards. We offer software dvelopers both customisable and out-of-the-box solutions to help you get started.
Learn more about upcoming GA4GH events. See reports and recordings from our past events.
Speak directly to the global genomics and health community while supporting GA4GH strategy.
Be the first to hear about the latest GA4GH products, upcoming meetings, new initiatives, and more.
Questions? We would love to hear from you.
Read news, stories, and insights from the forefront of genomic and clinical data use.
Publishes regular briefs exploring laws and regulations, including data protection laws, that impact genomic and related health data sharing
Translates findings from studies on public attitudes towards genomic data sharing into short blog posts, with a particular focus on policy implications
Attend an upcoming GA4GH event, or view meeting reports from past events.
See new projects, updates, and calls for support from the Work Streams.
Read academic papers coauthored by GA4GH contributors.
Listen to our podcast OmicsXchange, featuring discussions from leaders in the world of genomics, health, and data sharing.
Check out our videos, then subscribe to our YouTube channel for more content.
View the latest GA4GH updates, Genomics and Health News, Implementation Notes, GDPR Briefs, and more.
Following recent Clinical & Phenotypic Data Capture (Clin/Pheno) Work Stream
Phenopackets calls, we are moving into an active phase of infrastructure updates and deep interoperability with major health data standards, framed by your contributions on real-world implementation. As we have successfully done in the past, and to ensure these modifications are practical, sustainable, and reflective of diverse research practices and goals, we are starting a community consultation.
We are seeking detailed requirements, implementation feedback, and critiques from developers, clinical geneticists, data engineers, and consortia on the open discussion topics outlined below.
The proposed updates have been categorised into a structured project plan spanning technical baseline fixes, schema refinements, and external interoperability layers:
Upgrading serialisation baseline: We are exploring an upgrade to the latest versions of Protocol Buffers (such as moving from our current proto3 baseline to Protobuf Editions). This change would re-enable explicit optional field labels, directly addressing several community ticket requests. We need feedback on how these adjustments might impact downstream versioning, reference implementations, and your existing local builds.
Migration strategy: As we pave the way for a transition from Phenopackets v2.0 to v3.0, the working group has aligned on a development pipeline. We seek input on what automated transformation tooling, validation libraries (across Java, Python, and Rust), and quality-control checks your organisation would need to migrate existing datasets safely.
Episodic and recurring events: Conditions such as seizures occur multiple times over a lifespan. Because the current schema only captures a single Onset and Resolution per feature, we are evaluating a new field tentatively called Time_Observed or Age_Observed
Demographic variables (Gender, Sex, and Ethnicity): Handling these variables is highly complex across regions and clinical domains. Moving forward, we are proposing a strict structural separation between biological/genetic features (e.g. sex assigned at birth, chromosomal characteristics) and broader socio-administrative contexts (gender identity, ancestry, etc.). We need feedback on how your systems capture this data and which universally accepted ontologies (such as HANCESTRO or AFPO) should be prioritised.
Decoupling variant representation: For fields of study such as pharmacogenomics, variants of interest are often identified without an associated disease manifestation. Our working group is reviewing proposals to allow standalone variant interpretations outside of a locked diagnostic case hierarchy.
Survival time validation (Cardinality vs. Serialisation): Implementers have reported that certain language libraries (particularly in Python) unintentionally serialise missing integer values as zero. We are consulting the community on a proposal to update the schema/software to throw an absolute error if survival_time is explicitly set to 0 to prevent skewed survival data.
FHIR, OMOP, and Beacon ecosystems: Phenopackets rarely originate in a vacuum; they must be seamlessly extracted from Electronic Health Records (EHRs) and large observational databases. We welcome developers currently building automated ETL extraction tools or concept-mapping pipelines to help standardise our export workflows across Phenopackets, HL7 FHIR, and the OMOP Common Data Model.
To ensure transparency and centralised issue tracking, we have migrated these discussions into GitHub tickets.
Join the upcoming Phenopackets Community Calls, which will occur on:
July 23 at 7 am PT (check your local time here)
August 13 at 8 am PT (check your local time here)
August 27 at 7 am PT
September 10 at 8 am PT
Review the topics: A list of actively discussed topics is found in our Project Plan document (with links to GH tickets).
Comment on GitHub: Please visit our repository’s issue tracker to share your thoughts, edge cases, and votes directly on open tickets (linked in the document above).
We recognise that the ultimate success of Phenopackets relies on a collaborative, implementer-led approach to standard maturity. We thank you in advance for your time and expertise as we build a more connected, AI-ready future for precision medicine.